Clearbridge Investments, LLC Dynavax Technologies Corp Transaction History

Clearbridge Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.46 - $6.93 $4.11 Million - $8.23 Million	-1,187,491 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $301,871 - $544,267	-112,220 Reduced 8.63%	1,187,491 $4.25 Million
Q2 2019 Aug 14, 2019	BUY	$3.65 - $7.89 $505,061 - $1.09 Million	138,373 Added 11.91%	1,299,711 $0
Q1 2019 May 15, 2019	BUY	$7.08 - $12.09 $271,872 - $464,256	38,400 Added 3.42%	1,161,338 $8.49 Million
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $1.78 Million - $2.91 Million	218,805 Added 24.2%	1,122,938 $10.3 Million
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $10.7 Million - $14.5 Million	904,057 Added 1189548.62%	904,133 $11.2 Million
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $151 - $207	10 Added 15.15%	76 $1,000
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $131 - $179	9 Added 15.79%	66 $1,000
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $986 - $1,372	57	57 $1,000

287

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.62B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.